Antheia is a synthetic biology company engineering biomanufacturing processes to produce biosynthetic pharmaceutical ingredients, including biosynthetic key starting materials and active pharmaceutical ingredients. The company focuses on advanced biosynthesis in contained fermentation environments to create reliable, scalable supplies of essential medicines, aiming to fortify pharmaceutical supply chains and reduce drug shortages. Headquartered in the United States, Antheia highlights a platform that enables efficient, agile, and sustainable production of complex pharma ingredients to support drug development and discovery.